Observation versus late reintroduction of letrozole as adjuvant endocrine therapy for hormone receptorpositive breast cancer (ANZ0501 LATER): an open-label randomised, controlled trial
- Creator: Zdenkowski, N. , Forbes, J. F. , Mann, G. B. , Coates, A. S. , Gebski, V. , Davies, L. , Thornton, R. , Reaby, L. , Cuzick, J. , Green, M. , Boyle, F. M. , Kannourakis, G. , Gill, P. G. , Bayliss, E. , Saunders, C. , Della-Fiorentina, S. , Kling, N. , Campbell, I.
- Resource Type: journal article
- Date: 2016
Neoadjuvant chemotherapy with sequential anthracycline-docetaxel with gemcitabine for large operable or locally advanced breast cancer: ANZ 0502 (NeoGem)
- Creator: McCarthy, N. , Boyle, F. , Gebski, V. , Veillard, A. S. , Zannino, D. , Wilcken, N. , Reaby, L. , Lindsay, D. F. , Badger, H. D. , Forbes, J. F. , Zdenkowski, N. , Bull, J. , Leong, E. , Simpson, A. , Kannourakis, G. , Francis, P. A. , Chirgwin, J. , Abdi, E.
- Resource Type: journal article
- Date: 2014